Fig. 1: Neutralising titres to three circulating Australian SARS-CoV-2 isolates following prime-boost vaccination with INO-4800. | npj Vaccines

Fig. 1: Neutralising titres to three circulating Australian SARS-CoV-2 isolates following prime-boost vaccination with INO-4800.

From: Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein

Fig. 1

Y-axis represents log2 virus neutralising titre to the three Australian SARS-CoV-2 isolates following prime-boost vaccination with INO-4800, including three replicates of each ferret serum sample, represented as a circle for their mean. VIC01 and SA01 virus isolates, possessing a D614, are marked in red; whilst VIC31, possessing a G614, is marked in blue. The dark line on the chart for each virus isolate represents median titre, with the box indicating interquartile range and the vertical line representing the 95% confidence interval. Neutralisation titres against the different virus isolates are not significantly different.

Back to article page